Life-Style Medicine for Chronic Musculoskeletal Pain in Older People
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorChinese University of Hong Kong
About this trial
The goal of this clinical trial is to determine the clinical effectiveness of lifestyle medicine in reducing chronic musculoskeletal pain in older adults, as measured by pain intensity, pain interference, self-management efficacy, stress level, sleep quality, healthier diet, better quality of life, and cost-effectiveness, compared to a waitlist control group.
Participants will be randomly assigned to either the intervention or the waitlist group. The intervention group will meet the health coach face-to-face for four sessions to negotiate and set personalized health goals. The waitlist control group will continue to receive usual care without any additional intervention for 24 weeks. Both groups will complete three assessments: at the start of the study, one month after the intervention, and three months after the intervention. The waitlist control group will be offered the same intervention after completing the study.
Eligibility criteria
Qualifiers
chronic musculoskeletal pain, defined as pain that lasted for more than 3 months persistently or intermittently, including regional pain (joints, limbs, back, and/or neck)
a degenerative joint condition, such as osteoarthritis, and/or musculoskeletal complaints that fall under the classification of the International Classification of Disease-11 as "chronic primary musculoskeletal pain" or "chronic secondary musculoskeletal pain"
Pain intensity score ≥ 4 on a numerical rating scale of 10
stable baseline physical activity
Disqualifiers
patient with cancer-related pain
inflammatory rheumatic disease
a recent history of stroke or major surgery in the past 6 months
terminal illness
Trial design
Treatments tested in this trial
- Lifestyle medicine Health coaching
Treatment groups
268 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov